Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15838856 | 0.89 | ALDH1A1 (0.63) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL17996028 | 0.86 | ALDH1A1 (0.53) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL19880397 | 0.83 | TSHR (0.50) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL19880393 | 0.83 | TP53 (0.50) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL15835600 | 0.77 | TSHR (0.69) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL15835640 | 0.76 | TSHR (0.63) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL19880341 | 0.73 | ALDH1A1 (0.63) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL15838929 | 0.73 | ALDH1A1 (0.63) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL19880357 | 0.73 | ALDH1A1 (0.63) | TP53TSHRALDH1A1MAPTHPGD | |
| SCHEMBL9502828 | 0.72 | ALDH1A1 (0.61) | TP53TSHRALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9896535-B2 | Epoxy compound having alkoxysilyl group, method of preparing the same, composition and cured product comprising the same, and uses thereof | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2018-02-20 | — | — | US | disclosed |
| US-20160229948-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD OF PREPARING THE SAME, COMPOSITION AND CURED PRODUCT COMPRISING THE SAME, AND USES THEREOF | KOREA IND TECH INST (KR) | 2016-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160229948-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD OF PREPARING THE SAME, COMPOSITION AND CURED PRODUCT COMPRISING THE SAME, AND USES THEREOF | PFAS, FAR1, ELOVL1 | TP53 4299/4885TSHR 2992/4885ALDH1A1 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.